Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Clinical Study With Early Treatment Intensification In Patients With High- Risk Hodgkin Lymphoma, Identified As FDG-PET Scan Positive After 2 Conventional ABVD Courses

NCT00795613 is registered in ClinicalTrials.gov with Ospedale Santa Croce-Carle Cuneo as lead sponsor.

NCT NCT00795613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Clinical Study With Early Treatment Intensification In Patients With High- Risk Hodgkin Lymphoma, Identified As FDG-PET Scan Positive After 2 Conventional ABVD Courses
Lead sponsor
Ospedale Santa Croce-Carle Cuneo
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2008
Completion date
October 31, 2015
Enrollment
450 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma